Bit's 8th Annual World Cancer Congress - 2015

Following the great success of past seven years, BIT’s 8th Annual World Cancer Congress - 2015 will be held on 15-17, May, 2015 in Beijing, China.

The congress consists of twelve cooperative, specialized programs tailored to highlight the latest and most exciting discoveries in every area of cancer research and it will provide a unique opportunity for researchers from all over the world to meet, network, and forge new scientific interactions. Given the major worldwide importance in cancer research, cancer therapies, and new drug trials, we should not only help ensure we’re apprised of current developments in the field but also reflect on new progress and look toward future challenges. World opinion leaders are coming together to bring their depth of knowledge and experience to the program: molecular oncology, tumor immunology, cancer metastases, epidemiology, prevention, safety control, early detection, screening, imaging, treatment and translational and clinical research, presented with the emphasis on interdisciplinary challenges and supported by clinical interpretations needed for application of recent studies.

We have no doubt that networking with your colleagues, on an international scale, will result in a creative exchange of ideas and be personally rewarding. Beijing, the capital of the People's Republic of China, municipality and national central city, located in the north part of China and founded 3,000 years ago, is a thriving multi-cultural city and a venue not to be missed. We hope that you enjoy the meeting enough to join us in 2015.

Scientific Program
Opening Ceremony and Keynote Forum
08:30-12:00, May 15, 2015
(Parallel Sessions) Cancer Hospital Administrators Forum
08:30-17:00, May 16-17, 2015
(Paralleol Sessions) Cancer Screen, Preventin and Control
08:30-17:00, May 15-17, 2015
(Parallel Sessions) Breaking Research of Oncology
08:30-17:00, May 15-17, 2015
(Parallel Sessions) Cancer Prognostics and Diagnostics
08:30-17:00, May 15-17, 2015
(Parallel Sessions) Cancer Drug Discovery and Development
08:30-17:00, May 15-17, 2015
(Parallel Sessions) Best Clinical Practice on Cancer
08:30-17:00, May 15-17, 2015
(Parallel Sessions) Cancer Therapies
08:30-17:00, May 15-17, 2015
Renowned Speakers
  • International Renowned Speakers
  • National Renowned Speakers

Dr. Thomas Tursz, Professor & Honorary Director, Institut Gustave Roussy, France
Personalized Treatments of Cancer Patients

Dr. Russel J. Reiter, Professor, University of Texas Health Science Center, USA
Role of Melatonin as a Primary or Adjunct Treatment for Cancer

Dr. Irving Taylor, Professor & Vice Dean, University College London, UK
Recent Advances in Surgical Oncology

Dr. Michael G. Hanna Jr., CEO & Chairman Emeritus, Vaccinogen Inc., USA

Dr. Rajesh C. Shrotriya, CEO, Spectrum Pharmaceuticals, Inc., USA


Dr. Franz Recker, Professor, Kantonsspital Aarau AG, Switzerland
Risk-based Prostate Cancer Screening
Dr. Yi Charlie Chen, Professor of Biology, Alderson Broaddus University, USA
Chaetoglobosin K Induces Apoptosis and Cell Cycle Arrest through p53-dependent Pathways

Dr. Jian Cao, Professor of Medicine, Stony Brook University School of Medicine, USA
CEMIP, A Novel Molecule for Cancer Metastasis

Dr. William Redd, Professor, Mount Sinai School of Medicine, USA
Systematic Light Exposure to Control Cancer-Related Fatigue

Dr. Angela Sun, Executive Director, Chinese Community Health Resource Center, USA
Cancer Education and Control Programs Tailored for the Asian Communities in US

Mr. Ira S. Goodman, Associate Director for Administration, UC San Diego Moores Cancer Center, USA
A Model System and Setting for Translational and Clinical Cancer Research

Dr. Luigi Chieco Bianchi, Professor, University of Padova, Italy
The Critical Role of Microenvironment for Virus-driven Lymphoma Progression

Dr. Evaon Wong-Kim, Professor & Chair, Department of Social Work, California State University, East Bay, USA
Chinese Women with Breast Cancer and Their Fear of Recurrence and Their Psychosocial Needs

Dr. Waldemar L. Olszewski, Professor, Polish Academy of Sciences, Poland
The CC531 Cancer Cells Mummified in Pulverized Sodium Chloride Evoke Host Immune Reaction Leading to Destruction of Implanted Cancer Cells

Mr. Simon Holt, Consultant Surgical Oncologist, Prince Philip Hospital, UK
Synthetic 2D Imaging as a Solution to the Prolonged Reading Time Required for DBTs in Breast Screening

Dr. Yanping Zhang, Professor, Department of Radiation Oncology and Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, USA

Dr. Alexander V. Prokhorov, Director, Division of Cancer Prevention and Population Sciences, The UT MD Anderson Cancer Center, USA
Theory and Technology for Smoking Prevention Among Youth

Dr. Xaveer Van Ostade, Professor, University of Antwerp, Belgium
Protein Biomarkers for HPV Infection and Cervical Cancer in Cervicovaginal Fluid: towards A Self-diagnosis Test?

Dr. Jung Weon Lee, Professor, College of Pharmacy, Seoul National University, South Korea
TM4SF5-mediated Dissemination, Invasion and Circulating for Metastasis of Hepatic Cancer Cells

Dr. Alvaro Macieira-Coelho, Director of Research, French National Institute of Health, INSERM, France
Putative Mechanisms Responsible for the Decline of the Prevalence of Cancers during Organism Senescence

Dr. Gilbert C Faure, Professor, CHU de Nancy, University of Lorraine, France
Detection and Quantification of Malignant Cells in cerebrospinal fluid (CSFTCs) with Cell Search VERIDEX Should Improve Management of Carcinomatous Meningitis

Dr. Stephen J. O’Brien, Chief Scientific Officer, Theodosius Dobzhansky Center for Genome Bioinformatics , St. Petersburg State University, Russia
Genetic Architecture of Complex Infectious Diseases-Perspectives on NPC

Dr. Olivier Pardo, Team Leader, Department of Surgery & Cancer, Imperial College London, UK
FGF-2/S6K2 Signalling Promotes the Nucleo-cytoplasmic Shuttling of HnRNPA1 to Increase Cap-independent Translation of BCL-XL and XIAP

Dr. Fu-Li Yu, Professor Retired, Department of Biomedical Sciences, University of Illinois College of Medicine at Rockford, USA
Studies on the Naturally Occurring Anti-oxidants in Breast Cancer Prevention at the Initiation

Previous Event Report
Please Click here to Download

The 8th Annual World Cancer Congress (WCC-2015) was successfully held on May 15-17, 2015 in Beijing, China, with a theme of Bridging Research and Practice. More than 450 participants from over 42 countries and areas have attended the WCC-2015.
As the keynote speakers, Dr. Thomas Tursz, Honorary Director General & Professor Emeritus, Institut Gustave Roussy & The University Paris South (Paris XI), France; Dr. Yuxin Yin, Dean & Director, School of Basic Medical Sciences & Institute of Systems Biomedicine, Peking University, China; Dr. Irving Taylor, Professor & Vice Dean, University College London, UK; Dr. Yi Zeng, Honorary Dean, College of Life Sciences and Bioengineering, Beijing University of Technology, National Institute for Viral Diseases Control and Prevention, China; Dr. Stephen J. O’Brien, Chief Scientific Officer, Theodosius Dobzhansky Center for Genome Bioinformatics , St. Petersburg State University, Russia and Dr. Russel J. Reiter, Professor, UT Health Science Center, USA attended the opening ceremony and the Keynote Forum.
Depending on the warmly support and good suggestions from all of the participants, we are definitely sure BIT's 9th World Cancer Congress-2016, will be better and more successful than WCC-2015!

Exhibition and Poster

As part of the 2015 World Cancer Congress, an exhibition space will provide a unique opportunity for exhibitors to showcase their products and services to participants with interests in all areas of cancer. Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area by promoting frequent and repeated opportunities for delegates to visit the exhibits.

Exhibitors' advantages
• The exhibition will be visited by participants of the conference it means by your authentic target group from China and other countries.
• The exhibitors have the opportunity to present their exhibits in details, and have the opportunity for longer discussion with inquiring visitors – in most cases specialists – than during session discussions.


Exhibition Date:
Set-up date: May 14, 2015
Show dates: May 15-17, 2015 09:00-18:00
Place: Beijing, China

News Released

1. The world Well-known Overseas Cancer Research Center, e.g. Institut Gustave Roussy、UC San Diego Moores Cancer Center、The UT MD Anderson Cancer Center、University of Texas Health Science Center, have sent representatives to attend the WCC-2015

2. The well-known Chinese universities and hospitals, e.g. Chinese Academy of Science, Peking University, Fudan University, Sun Yat-sen University Cancer Center have sent representatives to attend the WCC-2015

3. Dr. Yi Zeng, the academician of Chinese Academy of Sciences and the world renowned virologist with more than 50 years’ research experience in virology, has confirmed to attend WCC-2015

4. Dr. Thomas Tursz, the Honorary Director of Institut Gustave Roussy, the largest cancer research institute in Europe, has confirmed to attend WCC-2015

5. Dr. Yuxin Yin, Director, Institute of Systems Biomedicine, Peking University, has confirmed to attend WCC-2015

6. Dr. Stephen J. O'Brien, the co-founder of the international Comparative Genomics field, has confirmed to attend WCC-2015

7. Many Overseas Medias and Journals are achieving cooperation with WCC-2015 in contribution.

Hosting Organization

Information Research Center of International Talents, SAFEA

Operating Organization

BIT Congress Inc.

Foreign Experts Databank of SAFEA-Dalian Branch

Honorary Chairman

Dr. Yi Zeng
Professor & Dean
Beijing University of Technology & Chinese Academy of Science, China

Honorary Chairman

Dr. Thomas Tursz
Professor & Honorary Director
Institut Gustave Roussy, France

Dr. Stephen J. O’Brien
Chief Scientific Officer
Theodosius Dobzhansky Center for Genome Bioinformatics
St. Petersburg State University, Russia


Dr. Huabei Chen,
State Administration of Foreign Experts Affairs, China

Conference Proceedings Publishing Journal (ISSN 2330-4049)
Official Travel Agency

BIT World Travel Service, Inc.

BIT’s Upcoming Events
Contact Us

Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China]
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Copyright © 2014-2015 BIT Congress Inc.